A recent investigation uncovered significant regulatory deficiencies within Morgan Stanley's wealth management operations.
When Walmart CEO, Doug McMillon, needs a bottle of wine, he doesn’t have to wait long, thanks to a fleet of drones serving ...
A former wealth manager contends she was unfairly denied disability payments after fibromyalgia and other health complaints ...
Morgan Stanley says it's bullish on medtech in 2025 and upgraded Intuitive Surgical (ISRG), Tandem (TNDM), Stryker (SYK), ...
Evercore Inc. hired veteran health-care banker Joseph Modisett as a senior managing director, according to a person briefed ...
Shares of Morgan Stanley MS dropped 0.45% to $130.44 Tuesday, on what proved to be an all-around mixed trading session for ...
Keefe Bruyette raised the firm’s price target on Morgan Stanley (MS) to $138 from $121 and keeps a Market Perform rating on the shares. The U.S. bank stocks have had a strong run following better ...
Internal company documents describe the bank’s weak anti-money-laundering controls and failure to complete due-diligence ...
Insights from analysts' 12-month price targets are revealed, presenting an average target of $123.62, a high estimate of $142 ...
The document itself reportedly acknowledged "weak" anti-money-laundering controls due to "longstanding issues globally" with ...
Morgan Stanley notes that BlackRock (BLK) has announced the acquisition of HPS Investment Partners for $12B in an all-stock transaction, ...
Citing the company's growth possibilities linked to its main medicine, Brukinsa (zanubrutinib), Morgan Stanley assigned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback